Long-term clinical outcome and phenotypic variability in hyperphosphatemic familial tumoral calcinosis and hyperphosphatemic hyperostosis syndrome caused by a novel GALNT3 mutation; case report and review of the literature

BACKGROUND: Hyperphosphatemic Familial Tumoral Calcinosis (HFTC) and Hyperphosphatemic Hyperostosis Syndrome (HHS) are associated with autosomal recessive mutations in three different genes, FGF23, GALNT3 and KL, leading to reduced levels of fibroblast growth factor 23 (FGF23) and subsequent clinica...

Descripción completa

Detalles Bibliográficos
Autores principales: Rafaelsen, Silje, Johansson, Stefan, Ræder, Helge, Bjerknes, Robert
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181413/
https://www.ncbi.nlm.nih.gov/pubmed/25249269
http://dx.doi.org/10.1186/s12863-014-0098-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4181413/
https://www.ncbi.nlm.nih.gov/pubmed/25249269
http://dx.doi.org/10.1186/s12863-014-0098-3

Ejemplares similares